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SUMMARY
Cells experience damage from exogenous and
endogenous sources that endanger genome stabil-
ity. Several cellular pathways have evolved to detect
DNA damage and mediate its repair. Although many
proteins have been implicated in these processes,
only recent studies have revealed how they operate
in the context of high-ordered chromatin structure.
Here, we identify the nuclear oncogene SET
(I2PP2A) as a modulator of DNA damage response
(DDR) and repair in chromatin surrounding double-
strand breaks (DSBs). We demonstrate that deple-
tion of SET increases DDR and survival in the
presence of radiomimetic drugs, while overexpres-
sion of SET impairs DDR and homologous recombi-
nation (HR)-mediated DNA repair. SET interacts
with the Kruppel-associated box (KRAB)-associated
co-repressor KAP1, and its overexpression results
in the sustained retention of KAP1 and Heterochro-
matin protein 1 (HP1) on chromatin. Our results are
consistent with a model in which SET-mediated
chromatin compaction triggers an inhibition of DNA
end resection and HR.
INTRODUCTION
Various types of agents from either exogenous or endogenous
sources constantly assault DNA (Ciccia and Elledge, 2010;
Hoeijmakers, 2001). DNA double-strand breaks (DSBs) are
together with interstrand cross-links among the less frequent
but the most toxic lesions because interaction between DNA
ends from different DSBs can produce tumorigenic chromo-
some translocations (Misteli and Soutoglou, 2009). DSBs are re-
paired by two main pathways: non-homologous end-joining
(NHEJ) and homologous recombination (HR) (Goodarzi and
Jeggo, 2013). NHEJ is used by cells to join broken ends by sim-
ple re-ligation (Wang and Lees-Miller, 2013). HR takes advan-
tage of the information encoded by the homologous template
of the sister chromatid to repair the DSB in an error-free manner
(Krejci et al., 2012).
DSBs trigger a complex cascade of signaling events known as
the DNA damage response (DDR). During the DDR, DNA dam-
age triggers the activation of phosphatidylinositol 3-kinases
ATM/DNAPK/ATR (ataxia telangiectasia mutated/DNA-depen-
dent protein kinase/ataxia telangiectasia and Rad3 related) and
the activation of cell-cycle checkpoint kinases, which in turn
pause the cell cycle until the DNA lesion is repaired (Bartek
and Lukas, 2007).
DNA in theeukaryotic cell is complexedwith histoneproteins to
form chromatin. Therefore, DNA repair generally occurs in the
context of highly structured chromatin and, as a result, the cell
has evolved mechanisms to open the chromatin structure and
facilitate repair (Lema^ıtre and Soutoglou, 2014; Soria et al.,
2012). Emerging evidence suggests that the ability of repair fac-
tors to detectDNA lesions is determinedbyhistonemodifications
around the lesion and involves chromatin-remodeling events
(Polo and Jackson, 2011). The most prominent DNA-damage-
induced histone modification in DNA DSB repair (DSBR) is the
phosphorylation of the C-terminal tail of H2AX, referred to as
gH2AX (Rogakou et al., 1998). Other chromatin proteins, such
as the Kruppel-associated box (KRAB)-associated co-repressor
KAP1, are alsophosphorylated byATM in response toDNADSBs
to further facilitate the decondensation of chromatin and allow
efficient repair (Goodarzi et al., 2008; Ziv et al., 2006). Although
there is increasing evidence that chromatin alterations are essen-
tial for efficient DSBR, the mechanisms underlying these chro-
matin changes are far from being fully understood.
In this study, we identified the oncoprotein SET as amodulator
of the DDR using a small interfering RNA (siRNA)-based screen
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of chromatin-related proteins. We show that depletion of SET in-
creases DDR and survival in the presence of radiomimetic drugs.
On the other hand, SET overexpression impairs DDR, DNA break
processing, and consequent repair by HR. SET interacts with the
co-repressor KAP1, and its overexpression leads to the sus-
tained retention of KAP1 and HP1 on chromatin. Our results sug-
gest a model in which this retention triggers an inhibition of
resection, impairing HR regulation.
RESULTS
The Nuclear Oncogene SET Is a Modulator of DDR in
Chromatin Surrounding DSBs
To evaluate the impact of high-ordered chromatin structure in
DDR and DNA repair in an unbiased way, we performed an
siRNA screen using a library with chromatin-related proteins
and their interaction partners. We identified the nuclear onco-
gene SET as a modulator of DDR since downregulation of SET
resulted in a significant increase in levels of gH2AX foci remain-
ing at 16 hr following Neocarzinostatin (NCS) treatment. This is
similar to the DNA repair defect observed in cells depleted for
XRCC4 (Figure 1A). Depletion of SET by two different siRNAs
validated the phenotype observed in the primary screen (Fig-
ure 1B). The knockdown efficiency was monitored by qRT-
PCR and western blot analysis (Figures S1A and S1B).
To validate the screen results in another cell type, we per-
formed western blot analysis in control U2OS cells and in cells
depleted for SET. We indeed observed higher damage-induced
gH2AX levels in cells where SET was downregulated (Figure 1C).
Interestingly, the level of gH2AX was increased immediately
upon DNA damage and was sustained at a higher level until
8 hr later (Figure 1C). These results point to two different possi-
bilities. First that depletion of SET results in persistent DNA dam-
age, suggesting a role of SET in facilitating repair of DNA lesions.
Another possible explanation is that downregulation of SET re-
sults in higher accessibility of H2AX to DDR kinases due to
altered chromatin conformation, without affecting the number
of unrepaired DNA breaks.
To differentiate between these two different possibilities, we
used comet assays to measure the number of DNA lesions in
control and SET-depleted cells. We did not observe a significant
increase of breaks at any time upon DNA damage in cells lacking
SET (Figure S1C). These results suggest that depletion of SET is
affecting neither the initial number of DNA lesions nor their repair
efficiency, as it was observed upon depletion of XRCC4, and
point to the second possibility.
To further investigate the role of SET in checkpoint activation,
we examined the phosphorylation status of Chk1 and Chk2 in
controls cells and SET-depleted cells. Depletion of SET did not
considerably alter Chk1 or Chk2 phosphorylation (Figure 1C),
further strengthening the point that SET depletion does not
lead to persistent DNA damage. Interestingly, and consistent
with the enhanced DDR, SET-depleted cells exerted slower re-
covery from the G2/M checkpoint arrest from control cells (Fig-
ure S1D). To further evaluate the involvement of SET in genome
integrity, we performed clonogenic survival assays in U2OS cells
treated with the radiomimetic drug phleomycin. We observed
that SET-depleted cells survive better in the presence of DNA
damage than control cells (Figure 1D), suggesting that downre-
gulation of SET renders DDR more efficient.
To investigate whether SET has a direct role in DDR, we tested
the recruitment of SET fused to GFP in laser-induced breaks.
Notably, SET was recruited to lesions instantly upon laser induc-
tion (Figure 1E). We also tested the recruitment of SET in endo-
nuclease-induced breaks by chromatin immunoprecipitation
(ChIP) (Lema^ıtre et al., 2014). We found that SET is clearly re-
cruited in I-SceI breaks, andwemonitored the efficiency of break
induction by gH2AX ChIP (Figures 1F and S1E). The observed
fluctuations in SET recruitment in the laser microirradiation ex-
periments prompted us to investigate whether the recruitment
of SET is cell cycle specific. To this end, we performed ChIP ex-
periments using SET antibody in cells arrested in G1/S or G2,
and we observed that the recruitment of SET is more pro-
nounced in cells arrested in G2 (Figures 1G and S1F).
All of the above results suggest that SET is recruited to DSBs
to regulate DDR activation.
SET Overexpression Impedes DDR and Recruitment of
HR Factors at Collapsed Forks and DSBs
The above findings support a potentially deleterious effect of
high levels of SET. Indeed, SET is found to be highly overex-
pressed in a variety of cancers (Christensen et al., 2011; Li
et al., 2012). To assess the impact of SET overexpression in
genomic instability, we established a cellular model for SET
overexpression in U2OS cells (Figures S2A–S2C). We generated
U2OS stable cell lines overexpressing SET fused to GFP
Figure 1. The Nuclear Oncogene SET as a Factor Affecting the DDR
(A) SET as a major hit of a high-throughput siRNA screen to identify new chromatin-related DDR factors. HeLa cells were transfected with siGFP, siXRCC4, or
siSET (pool) in 96-well plates. 72 hr post-transfection cells were treatedwith 50 ng/ml NCS for 15min before being released for another 16 hr. Cells were then fixed
and immunostained for gH2AX. Levels of gH2AX intensity were measured by an automated microscope.
(B) As in (A), the initial screen was validated using two individual siRNAs for SET (siSET-1 and -2).
(C) Western blot analysis of U2OS cells transfected with siSCR or siSET for 72 hr before being treated with 50 ng/ml NCS for 15min and released for different time
points is shown.
(D) Clonogenic survival of U2OS cells transfected with siSCR or siSET and treated with increasing concentrations of phleomycin. SEM represents the errors from
three independent experiments. Statistical significance in all experiments was calculated using the t test (*p < 0.05, **p < 0.01, ***p < 0.001).
(E) Laser-induced DNA damage. Live cell imaging was performed after laser irradiation of U2OS cells co-expressing GFP-SET and mRuby2-Ku80 (scale bar
represents 10 mm).
(F) ChIP for SET and gH2AX at the indicated time points upon Doxycycline addition in Hela111 cells is shown. Values were normalized to input DNA and are
representative of two independent experiments.
(G) ChIP for SET at the indicated time points upon Doxycycline addition in Hela111 cells arrested in G1/S or G2 phase of the cell cycle. Values were normalized to
the non-treated sample and are representative of two independent experiments.
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(GFP-SET). A U2OS stable cell line overexpressing GFP was
used as negative control. The level of overexpression of the
SET protein was three to four times higher than the endogenous
level of SET (Figure S2C). GFP-SET displayed nuclear localiza-
tion similar to the endogenous protein (Figure S2B), and the
overexpressed fusion protein did not alter the localization or
the partition of endogenous SET to chromatin (Figure S2D).
To first test whether SET overexpression limits DDR, we eval-
uated gH2AX induction in GFP and GFP-SET cells upon NCS
treatment. Interestingly, although, the DDR mounting in asyn-
chronous SET-overexpressing cells was quite similar to control
cells, gH2AX upon SET overexpression was significantly
affected in cells arrested in G2 (Figure 2A). This observation is
in line with the enhanced recruitment of SET in DNA lesions
occurring in G2 (Figure 1G).
To assess the impact of SET overexpression in genomic insta-
bility, we performed clonogenic survival assays in U2OS GFP
andGFP-SET cells in the presence of different damaging agents.
We observed that cells overexpressing SET are mainly sensitive
to the replication stress agent camptothecin and not phleomycin
(Figures 2B and S2E). Therefore, our results strengthen the
notion that SET overexpression affects the DDR or repair of
lesions occurring in S-G2 phase.
In line with these results, cells overexpressing SET, although
when not challenged do not demonstrate major changes in cell
cycle or proliferation rates (Figures 2C and S2H), exerted slower
progression through S-G2 phase compared to GFP cells when
challenged with phleomycin (Figure S2F) and the replication
stress agent hydroxyurea (HU) (Figure 2C), further suggesting
an impairment in sensing or repairing lesions occurring during
S phase. To further analyze this phenomenon with a specific S
phase marker, we performed BrdU staining after treatment
with HU in U2OS cells overexpressing GFP-SET or GFP (Fig-
ure S2G). In agreement with the previous observation, we
observed a substantial increase in the proportion of challenged
cells in S phase when SET was overexpressed (Figure 2C).
To investigate whether the delay in S and G2 phase progres-
sion is due to a defect in DDR at collapsed forks caused by
SET overexpression, we compared gH2AX in control cells and
in cells overexpressing SET, treated with HU and released 0, 8,
10, 12, 16, and 24 hr after the treatment. We found that,
although the amount of collapsed forks in both conditions was
the same, exemplified by the levels of RPA phosphorylation at
S4/S8 (Figure 2D), there was a notable impairment in gH2AX in-
duction (Figures 2D and S3A) in cells overexpressing SET. These
results suggest an inhibitory role of SET in DDR signaling at
stalled forks.
Next, we investigated whether SET overexpression had an
impact on HR at collapsed forks. To this end, we assayed the
recruitment of theHR repair factors BRCA1 andRAD51. Interest-
ingly, the number of SET-overexpressing cells that displayed
BRCA1 and RAD51 foci upon HU treatment was reduced at least
to 50% compared to GFP-expressing cells (Figures 3A and 3B).
Overall, these results show that overexpression of SET impedes
DDR and recruitment of HR factors at collapsed forks.
To test whether a similar phenomenon was observed at endo-
nuclease-induced DSBs in SET-overexpressing conditions, we
used a cellular system in which a single DSB can be created at
a specific genomic site (Lema^ıtre et al., 2012; Soutoglou and
Misteli, 2008). In this system, expression of I-SceI induces a
DSB that can be visualized by monitoring localization of GFP-
tagged lac repressor (GFP-lacI) and the early DDR marker
gH2AX (Figures 3C and 3D). Remarkably, SET overexpression
led to a defect in the recruitment of BRCA1 and RAD51 at the
lacO/I-SceI array (Figure 3E). These observations were not due
to chances of the cell-cycle profile, as SET overexpression had
no impact on the cell cycle (Figure S3B). Similar results were ob-
tained when RAD51 and BRCA1 foci were quantified in GFP and
GFP-SET cells that were treated with NCS (Figures S3C–S3E).
We next used the lacO-lacI/I-SceI system to evaluate the
impact of direct SET tethering to chromatin on the recruitment
of HR proteins to DSBs. To this end, SET was fused to lacI and
mCherry to generatemCherry-lacI-SET (Figures 4A and 4B). Sta-
ble association of SET on chromatin had a dramatic effect on
BRCA1 and RAD51 loading at the breaks (Figure 4C). To test
whether the defect in BRCA1 association with breaks in condi-
tions that SET is overexpressed has an impact on resection of
these breaks, we assessed recruitment of CtIP and phosphory-
lation of RPA upon tethering of SET at the lacO chromatin.
Indeed, SET tethering affected the recruitment of CtIP and the
phosphorylation of RPA at I-SceI breaks (Figure 4D). Similarly,
SET tethering did not change the cell-cycle profile (Figure S4A).
To test whether the defect in resection and recruitment of HR
factors when SET is overexpressed leads to a defect in HR, we
used the DR-GFP system (Figure S4B; Pierce et al., 1999). As ex-
pected, depletion of BRCA1 led to a decrease in the HR effi-
ciency (Figures 4E and S4C). In accordance with the previous
observations of HR factor recruitment, SET overexpression
decreased significantly the efficiency of HR without altering the
cell-cycle patterns, and depletion of SET had the opposite effect
(Figures 4E, S4C, and S4D).
Next we investigated whether the role of SET on HR had an
impact on NHEJ. As depicted in Figure 4F, SET overexpression
increased NHEJ levels. This result at the same time excluded the
possibility of defective I-SceI cutting efficiency in the HR exper-
iment due to increased chromatin compaction after SET overex-
pression. To study the role of SET in NHEJ, we checked the
kinetics of recruitment of 53BP1 at the I-SceI breaks (Figures
S4E–S4H). Interestingly, although the percentage of cells that
exerted 53BP1 colocalization with the lacO/I-SceI locus was
not different between control cells and cells overexpressing
SET at a time point when there was peak DDR, inducible expres-
sion of I-SceI demonstrated that 53BP1 was recruited earlier in
cells that overexpressed SET (Figures S4G and S4H).
SET Interacts with KAP1 and Facilitates KAP1 and HP1
Retention to Chromatin
To investigate the mechanism of action of SET, we searched for
potential interaction partners. SET immunoprecipitation followed
by mass spectrometry revealed co-repressor KAP1 (KRAB-
associated protein-1) as an interacting partner of SET. To verify
this interaction, we performed GFP-Trap immunoprecipitation
experiments using the previously described U2OS GFP and
GFP-SET cell lines. We observed an interaction between SET
and KAP1 that did not depend on the presence of DNA damage
(Figure 5A). Furthermore, the addition of Benzonase at the CoIP
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demonstrated that the interaction of SET and KAP1 is DNA inde-
pendent (Figure S5A).
To further explore the functional significance of SET and KAP1
interaction, and to test whether KAP1 is involved in any of the
phenotypes related to SET overexpression, we examined its
localization in cells overexpressing SET. Immunofluorescence
staining showed similar KAP1 nuclear localization in U2OS cells
overexpressing GFP-SET or GFP (Figure 5B). On the other hand,
when immunofluorescence was performed under conditions in
which all soluble proteins were pre-extracted before fixation,
we observed a dramatic increase of KAP1 retention to chromatin
when SET was overexpressed (Figure 5B, bottom, quantified in
Figure 2. Overexpression of SET Affects Survival, Cell-Cycle Progression, and DDR Signaling during G2 and after Induction of Replication
Stress
(A) Western blot analysis of asynchronous G1/S or G2-arrested U2OS GFP and U2OS GFP-SET cells treated with 50 ng/ml NCS for 15 min and released for the
indicated time points is shown.
(B) Clonogenic survival of U2OS cells stably overexpressing GFP or GFP-SET with increasing concentrations of camptothecin. SEM represents the errors from
three independent experiments.
(C) Cell-cycle analysis of U2OS GFP (left) and U2OS GFP-SET (right) cell lines after treatment with 10 mM HU for 24 hr (arrests cells in the border of G1-S) and
release for the indicated time points is shown (analyzed using propidium iodide staining).
(D) Western blot analysis of U2OS GFP and U2OS GFP-SET cells treated with 10 mM HU for 24 hr and released for the indicated time points is shown.
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Figure 3. Overexpression of SET Impairs Recruitment of HR Factors on Collapsed Replication Forks and Endonuclease-Induced DSBs
(A and B) Immunofluorescence staining of U2OSGFP andGFP-SET cells with RAD51 and BRCA1 after treatment with 10mMHU for 24 hr and release for another
8 hr (top) (scale bar represents 10 mm). Quantification is given of RAD51-foci-positive cells (>3 foci per cell) or BRCA1-foci-positive cells (>5 foci per cell) after
(legend continued on next page)
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Figure 5C). The enhanced retention of KAP1 to chromatin in
GFP-SET cells also was observed by biochemical cell fraction-
ation (Figure 5D). To further strengthen this observation, we
tested the chromatin retention of exogenously expressed cher-
ry-KAP1 in GFP and GFP-SET cells after pre-extraction. We
observed that, although the levels of cherry-KAP1 in GFP and
GFP-SET cells were pretty similar (Figure S5B), the retention of
cherry-KAP1 to chromatin after pre-extraction was enhanced
in SET-overexpressing cells (Figures S5C and S5D). These re-
sults point to a role of SET in KAP1 chromatin retention.
KAP1 is known to mediate gene silencing by recruiting the
methyltransferase SETDB1, which specifically tri-methylates
histone H3 at Lys-9 (H3K9me3) (Schultz et al., 2001, 2002). To
examine whether KAP1 chromatin retention in SET overexpres-
sion leads to increased H3 K9 methylation, we performed
immunofluorescence in U2OS GFP and GFP-SET cells after
pre-extraction of soluble proteins. Following the pattern of
KAP1, H3K9me3 levels were also higher in SET-overexpressing
conditions (Figure 5E, quantified in Figures 5F and S5E, right).
KAP1-mediated gene silencing also involves the recruitment
of Heterochromatin protein 1 (HP1s: HP1a, b, and g) through
direct protein-protein interaction with KAP1, or through binding
to H3K9me3 mark (Nielsen et al., 1999; Ryan et al., 1999). In
line with the previous observations, SET overexpression led to
a higher retention of HP1s in chromatin (Figure 5G). This phe-
nomenon was particularly pronounced with HP1g, which ap-
peared globally perturbed, being more pan-nuclear than in the
heterochromatic foci, and was not observed in another chro-
matin-bound protein like TBP (Figures 5G and S5F).
In line with the above observations, tethering of SET at the
lacO led to the retention of KAP1 and HP1s at the locus (Figures
6A, 6B, S6A, and S6B). Among the HP1s, the most significant
effect was observed with HP1g (Figure 6B). Similar results
were obtained when an I-SceI DSB was induced adjacent to
the lacO locus. It is noteworthy that HP1g colocalization with
the array exerted a 40% reduction upon induction of the I-SceI
break in cells expressing the lac repressor alone (Figure 6B),
showing that HP1g is evicted from the lacO chromatin upon
DNA damage. Interestingly, upon SET tethering eviction of
HP1g was not observed, suggesting that SET inhibits the evic-
tion of HP1g and retains it stably bound to chromatin (Figure 6B).
Chromatin Compaction Inhibits Resection and
Recruitment of HR Factors
Retention of HP1s in chromatin is likely to result in chromatin
compaction. Indeed, cells overexpressing GFP-SET had smaller
nuclear size compared to cells that expressed GFP (Figures S6C
and S6D). Moreover, GFP-SET cells exerted resistance tomicro-
coccal nuclease (Mnase) accessibility compared to GFP cells
(Figure 6C), another indication of chromatin compaction. In
agreement with this observation, detailed quantification of repli-
cation patterns in GFP and GFP-SET cells demonstrated that,
although cells that overexpress SET have the same number of
cells in S phase, they have a higher population of cells in late
S phase than control cells, and SET-depleted cells have the
reverse phenotype with less cells in late S (Figures S6E–S6H).
These observations altogether point to a role of SET in chromatin
compaction.
To investigate whether the chromatin compaction mediates
the SET-dependent defect in loading of HR factors in DNA
lesions, we alleviated chromatin compaction using Trichostatin
A (TSA) (To´th et al., 2004) and assessed RAD51 and BRCA1
foci formation at lacO/I-SceI breaks after SET tethering. As
shown in Figure 6D, TSA treatment rescued the defect on
BRCA1 and RAD51 at lacO/I-SceI breaks. Furthermore, TSA
treatment rescued the recruitment of CtIP and RPA phosphory-
lation at the lacO/I-SceI locus, suggesting that chromatin
compaction impacts resection (Figure 6E). Similarly, TSA treat-
ment rescued the decrease observed in gH2AX at collapsed
forks upon HU treatment (Figure 6F).
To test whether retention of KAP1 to chromatin is sufficient to
induce the effects seen by SET tethering, we fused KAP1 to
mCherry-lacI and tethered it to lacO. Interestingly, KAP1 teth-
ering to lacO resulted in impairing the recruitment of RAD51,
BRCA1, and CtIP after break induction with I-SceI (Figure S6I),
which is in total accordance with the results coming from SET
tethering on the chromatin. Moreover, tethering of KAP1 on the
lacO array accumulated all three HP1s on the chromatin, but
HP1g seemed to be the one that was present almost 100%along
with KAP1 (Figure S6J).
As HP1g is themost pronounced at the lacO chromatin among
all HP1s when SET is tethered, we investigated whether HP1g
retention could be part of themechanism leading to the resection
impairment observed in SET-overexpressing conditions. There-
fore, we asked whether HP1g tethering to the lacO array by
fusion with lac repressor and with GFP could recapitulate the
SET-tethering phenotype (Figures 7A and S7A–S7C). Tethering
of HP1g at the lacO array resulted in a substantial decrease in
BRCA1, RAD51, CtIP, and phosphorylated RPA recruitment
upon I-SceI break induction compared to the lac repressor alone
(Figures 7A and 7B). This phenotype was specific to HP1g since
it was not observed upon tethering of HP1a or b (Figures 7A
and 7B).
To further investigate the involvement of HP1g in SET-
dependent functions, we assayed resection and loading of
BRCA1 and RAD51 at the lacO/I-SceI break upon SET tethering
in control cells and cells depleted for HP1g. Although when SET
was tethered to chromatin CtIP, BRCA1, RAD51 loading, and
treatment with 10 mMHU and release for the indicated time points. Photos of at least 100 cells were analyzed for each condition. SEM represents the errors from
three independent experiments.
(C) Schematic representation of the lacO-lacI/I-SceI system. An array of 256 repeats of the lacO sequence flanked by an I-SceI site is stably integrated into an
U2OS cell line.
(D) Immunofluorescence of the GFP lacI-lacO U2OS cells with gH2AX in the presence or absence of I-SceI, indicating the colocalization of gH2AX foci with the
lacO array in the presence of I-SceI (scale bar represents 10 mm), is shown.
(E) Quantification of the colocalization of RAD51, BRCA1, and P-RPA foci with the lacO array in at least 100 GFP lacI-lacO U2OS cells transfected with FLAG or
FLAG-SET in the presence or absence of I-SceI. SEM represents the errors from three independent experiments.
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Figure 4. Tethering of SET on the Chromatin Impairs Resection and HR and Enhances NHEJ
(A) Schematic representation of SET tethering on the lacO-lacI/I-SceI system is shown.
(B) Immunofluorescence staining of the lacOU2OS cells transfected withmCherry-lacI-SET with gH2AX antibody in the presence or absence of I-SceI, indicating
the colocalization of gH2AX foci with the lacO array in the presence of I-SceI (scale bar represents 10 mm), is shown.
(C and D) Quantification of the colocalization of RAD51, BRCA1, CtIP, and P-RPA32 S4/8 foci with the lacO array in at least 100 lacO U2OS cells transfected with
mCherry-lacI or mCherry-lacI-SET in the presence or absence of I-SceI. SEM represents the errors from three independent experiments.
(legend continued on next page)
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phosphorylated RPA at the lacO/I-SceI was decreased
compared to cells that expressed mCherry-lacI alone, downre-
gulation of HP1g partially rescued this defect (Figures 7C and
S7E). Downregulation of HP1a or b did not show any rescue
and, on the contrary, affected resection and loading of HR pro-
teins (Figure S7F), as shown previously (Baldeyron et al., 2011;
Lee et al., 2013; Soria and Almouzni, 2013). The depletion of
HP1s by siRNA was tested by western blot (Figure S7G). These
findings point to a role of SET in KAP1 and HP1 retention to chro-
matin, and, when this is exaggerated, it results in impaired HR.
Depletion of SET in conditions where HP1g was tethered to
lacO chromatin did not rescue the recruitment of BRCA1 and
(E) FACS analysis of DR-GFP cells transfected with FLAG or FLAG-SET or siSCR, siSET, or siBRCA1 at the same time with either BFP- or BFP-I-SceI-expressing
vector. SEM represents the errors from three independent experiments.
(F) FACS analysis of GCV6 cells transfectedwith FLAGor FLAG-SET at the same timewith either BFP or BFP-I-SceI-expressing vector. SEM represents the errors
from three independent experiments.
Figure 5. SET Interacts with KAP1 and Facilitates KAP1, SETDB1, and HP1 Retention on the Chromatin
(A) Immunoprecipitation (IP) of cell extracts from U2OSGFP and GFP-SET cells treated or not with 10mMHU using the GFP-trap column. The inputs and eluates
were analyzed by western blots against the proteins KAP1 and GFP.
(B) Immunofluorescence staining of U2OS GFP and GFP-SET cells with KAP1 antibody with or without pre-extraction is shown.
(C) Levels of KAP1 intensity after pre-extraction were measured by an automated microscope.
(D) Biochemical fractionation of U2OS GFP and U2OS GFP-SET cells. Fraction I (FI) represents the cytoplasmic fraction, Fraction III (FIII) the nuclear soluble
fraction, and Fraction IV (FIV) the insoluble/chromatin fraction. All fractions were analyzed by western blot.
(E) Immunofluorescence staining of U2OS GFP and GFP-SET cells using antibodies against H3K9me3 after pre-extraction of nuclear soluble proteins prior to
fixation is shown.
(F) Levels of H3K9me3 intensity after pre-extraction were measured by an automated microscope.
(G) Immunofluorescence staining of U2OS GFP and GFP-SET cells using antibodies against and HP1a, b, and g after pre-extraction of nuclear soluble proteins
prior to fixation is shown (scale bar represents 10 mm).
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Figure 6. SET Tethering on Chromatin Induces Compaction through KAP1 and HP1g Retention and TSA-Induced Relaxation Rescues
Resection and HR Factors’ Recruitment
(A and B) Quantification is given of the colocalization of KAP1 (A) and HP1g (B) foci with the lacO array in at least 100 lacO U2OS cells transfected with mCherry-
lacI or mCherry-lacI-SET in the presence or absence of I-SceI.
(legend continued on next page)
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RAD51, suggesting that HP1g is downstream of SET and, once
tethered to chromatin by other means, can exert its function
(Figure S7D).
Finally, the tight relationship among SET, H3K9me3, andHP1g
was examined by immunohistochemical and immunofluorescent
means in serial sections from head and neck and colon cancers.
SET had low expression in normal tissues, whereas its detection
in cancerous lesions was evident (data not shown). Most impor-
tantly and in accordance with our model, the serial section anal-
ysis clearly depicted a correlation in increased levels of SET,
H3K9me3, and HP1g (Figures 7D and 7E).
Our results altogether propose a model in which SET associ-
ates with DNA breaks to moderate DDR and DNA repair by HR
in the surrounding chromatin by regulating chromatin compac-
tion. SET binds KAP1 and its overexpression leads to amplifica-
tion of its normal function due to increased retention of KAP1 and
HP1s to chromatin, leading to a repressive micro-enviroment for
HR as the inefficient chromatin opening can inhibit resection and
recruitment of major DNA repair factors (Figure 7F).
DISCUSSION
SET/TAF-Ib, also known as I2PP2A and INHAT, was originally
identified as a translocated gene in acute undifferentiated leuke-
mia (Adachi et al., 1994). It is a multi-tasking protein and it was
shown to be a potent inhibitor of phosphatase 2A (PP2A) (Li
et al., 1996). It belongs to the NAP1 family of histone chaperones
(Kawase et al., 1996; Muto et al., 2007). Other studies have
shown that SET/TAF-Ib binds to nucleosomal histones and in-
hibits histone acetylation by masking histone tails as a compo-
nent of the INHAT complex (Kutney et al., 2004; Schneider
et al., 2004). Here we describe a novel function of SET in DDR
and DNA repair. We have found that SET is an endogenous
modulator of DDR and, when depleted, enhances DDR and sur-
vival in radiomimetic drugs. In addition, we show that SET over-
expression impairs DDR and HR and reduces survival in
response to damaging agents. In line with our observations,
SET depletion also was found to increase gH2AX in a high-con-
tent screen for chromatin-related proteins that affect DDR upon
ionizing radiation (IR) (Floyd et al., 2013). The functions of SET in
our study are independent from its role at the INHAT complex,
since pp32, another component of the complex, did not exert
similar functions in DDR andDNA repair as SET (data not shown).
In search of a potential mechanism of action of SET, we found
that it interacts with KAP1 and mediates its retention to chro-
matin. Our results altogether suggest a model in which SET-
dependent KAP1 chromatin retention leads to the retention of
its interaction partner, the methyl-transferase SETDB1, and an
increase in its target histone modification (Figures 5B–5F and
S5E). Consequently, this heterochromatic mark triggers
increased retention of the HP1 proteins to chromatin. In the pres-
ence of DNA damage, KAP1 and HP1s are not properly released
from chromatin in SET-overexpressing cells, leading to inacces-
sibility of DNA repair factors and subsequent repair defect (Fig-
ure 4E). Given that the characterization of the interaction
domain(s) of SET with KAP1 was not the focus of this study,
future studies are necessary to uncover how SET recruits
KAP1 and if its histone chaperone activity is connected with it.
Recent studies have highlighted the importance of KAP1
phosphorylation in HP1 and CHD3 release from heterochromatin
to allow chromatin relaxation and access to DNA repair factors,
leading to the efficient repair of heterochromatic lesions (Ayoub
et al., 2008; Bolderson et al., 2012; Garvin et al., 2013; Goodarzi
et al., 2011; White et al., 2012). For HP1b, this release was
dependent on its phosphorylation by casein kinase II (Ayoub
et al., 2008). On the other hand, all three HP1 isoforms are shown
to accumulate in DNA lesions through their chromoshadow
domain (Luijsterburg et al., 2009; Soria and Almouzni, 2013).
These contradictory findings can be reconciled to a model in
which HP1 mobilization from DSBs is followed by its accumula-
tion at these or other sites of damage. In accordance with this
bimodal behavior of HP1s, although ATM is activated to induce
chromatin relaxation by KAP1 phosphorylation immediately after
damage, it was shown that, in breaks in which resection had
occurred, ATM activity was diminished, pointing to a need for
chromatin reconstitution for late steps of HR to occur (Geuting
et al., 2013). Our results are in agreement with the necessity of
open chromatin for DDR and DNA end resection.
Our results reveal distinct behavior of HP1 isoforms in
response to DNA damage. First, we show that exclusively
HP1g, and not a or b, is released from I-SceI-induced breaks.
Moreover, persistent binding of HP1g to chromatin inhibits
resection and subsequent strand invasion, exemplified by the
defective recruitment of RAD51 and BRCA1 (Figures 7A and
7B). Our observations are in line with recent data that revealed
differences in how the HP1 isoforms regulate HR (Soria and
Almouzni, 2013). Although, HP1a and HP1b promote RPA phos-
phorylation, recruitment of RAD51, and HR stimulation, HP1g
plays an inhibitory role, suggesting that its release is necessary
for efficient repair by HR. Also, the effect of chromatin compac-
tion on DNA end resection observed by SET overexpression is in
keeping with recent studies, which found that HR is activated at
DSBs located within actively transcribed genes that reside in
euchromatin (Aymard et al., 2014; Jha and Strahl, 2014; Pai
et al., 2014).
One study described SET as a chaperone of histone H1 and
demonstrated that SET is regulating the eviction of histone H1
from chromatin (Kato et al., 2011). Moreover, knockout of
some of the histone H1 isoforms leads to an increase in DDR
due to chromatin decondensation (Murga et al., 2007). Our
data show that SET overexpression leads to chromatin compac-
tion and reducedDDR that fitsmore with enhanced binding of H1
to chromatin than enhanced eviction. Possible explanations for
this discrepancy are that prolonged overexpression of SET leads
(C) MNase digestion of chromatin from U2OS GFP and GFP-SET nuclei and quantification (right) are shown.
(D and E) As in (A) and (B), the lacO U2OS cells also were treated with either DMSO or TSA for 8 hr prior to fixation and cells were immunostained against RAD51,
BRCA1, CtIP, and P-RPA32 S4/8. SEM represents the errors from three independent experiments.
(F) Western blot analysis of whole-cell extracts of U2OS GFP and GFP-SET cells that were treated with 10 mMHU for 24 hr and released in DMSO or TSA for the
indicated time points is shown.
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to an imbalance of the different histone H1 isoforms, leading to
complex phenotypes, or that the functions of SET on DSB repair
are independent of its histone chaperone activity.
SET is highly overexpressed in various types of cancers (Ada-
chi et al., 1994; Christensen et al., 2011; Jiang et al., 2011; Leo-
poldino et al., 2012; Li et al., 2012; Ouellet et al., 2006), and in
certain cases SET levels correlate with disease severity (Chris-
tensen et al., 2011). Although, it was proposed that SET leads
to tumorigenesis because it inhibits the tumor suppressor
PP2A or metastasis suppressor NM23-H1 (Switzer et al.,
2011), our results suggest that defective DNA repair by HR in
cells that overexpress SET also might contribute to the initiation
of carcinogenesis and/or progression.
Moreover, SET has been shown to interact with the tumor
suppressor p53 (Kim et al., 2012). SET inhibits p53 acetylation
thus repressing transcription of its target genes, leading to
impairment of p53-dependent cell-cycle arrest and apoptosis.
These results are fitting with the observation that SET is
overexpressed in cancer. Although, we haven’t directly
tested the activation of p53 target genes in our system, the
reduced cell survival upon DNA damage in SET-overexpressing
cells could be attributed to impaired apoptosis and cell-cycle
arrest.
Therefore, SET represents an attractive therapeutic target for
cancer therapy. In keeping with this, recent studies have re-
ported the development of peptides like COG112 (Switzer
et al., 2011) that inhibit the binding of SET with PP2A or NM23-
H1 and release them from the SET inhibitory effect. In addition,
our results demonstrating that SET-overexpressing cells are hy-
persensitive to replication stress agents, such as camptothecin
(Figure 2B), suggest that these types of agents, which are widely
used in the clinic, may be exploited to target tumors expressing
high levels of SET.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections
U2OS and U2OS-lacO-ISceI-Tet19 cells were cultured at 37C in DMEM sup-
plemented with glucose (4.5 g/l), 10% fetal calf serum, and gentamycine
(40 mg/ml). U2OS GFP and U2OS GFP-SET cells were cultured as U2OS cells
with the addition of 0.8 g/ml G418. FuGene 6 (Promega) and Interferin (Poly-
plus Transfection) were used for transient transfections of plasmids and siRNA
transfections (20 nM final concentration of siRNA), respectively.
Laser Microirradiation
For 405-nmUV-laser irradiation, experiments were carried out as described by
Kruhlak et al. (2006).
ChIP
The ChIP was performed as previously (Lema^ıtre et al., 2014) with a few
changes as described in the Supplemental Experimental Procedures.
GFP-Trap
U2OS GFP and GFP-SET cells were collected in lysis buffer (10 mM Tris/Cl
[pH 7.5], 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40, and protease inhibitor
cocktail [Roche]), incubated for 20 min on ice and centrifuged for another
20 min (14,000 rpm, 4C). The supernatant was incubated with GFP-trap
beads (Chromotek) for 2 hr at 4C under rotation. Beads were washed and
eluted in SDS sample buffer.
Biochemical Fractionation
Biochemical fractionation was carried out as previously described (Andegeko
et al., 2001).
HR and NHEJ Assay
DR-GFP cells (HR) and GCV6 cells (NHEJ) (Rass et al., 2009) were transfected
with pcDNA-FLAG or pcDNA-FLAG-SET or the appropriate siRNAs in combi-
nation with either BFP-C1 or BFP-C1-I-SceI. Then 72 hrs after transfection, the
cells were collected and fixed with 4% paraformaldehyde in PBS for 10 min at
room temperature. Samples were submitted to fluorescence-activated cell
sorting (FACS) analyzed by FlowJo.
MNase Assay
The assay was carried out as previously described with a few changes (Ziv
et al., 2006). In brief, cells were harvested and nuclei immediately isolated us-
ing hypotonic buffer. Freshly isolated nuclei were digested for 30 s at 25Cwith
MNase (Roche) at a concentration of 10 U per 75 ml digestion buffer (15 mM
Tris-HCl [pH 7.4], 60 mM KCl, 15 mM NaCl, 0.25 M sucrose, 1 mM CaCl2,
and 0.5 mM DTT). Genomic DNA was purified and separated by electropho-
resis in 1.2% agarose gel.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.03.005.
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Supplemental Figure Legends 
Figure S1 (Related to Figure 1): (A) & (B) Silencing of SET as measured by relative 
mRNA levels or by Western blot analysis. (C) Neutral Comet assay. Left panel: U2OS 
cells transfected with siSCR, siSET or with siXRCC4 were treated with 200 ng/mL 
NCS for 15 min and released for 0 or 16h before being subjected to comet assay. Right 
panel: Silencing of SET and XRCC4 as confirmed by Western blot analysis. (D) Cell 
cycle analysis of U2OS cells transfected with siSCR (left panel) or siSET (right panel) 
cell lines after treatment with 50 ug/ml for 1 hour and release for the indicated time 
points and analyzed using Propidium Iodide staining. (E) Schematic representation 
of the HeLa-111-ptight cells. An array of 256 repeats of the LacO sequence flanked by 
an I-SceI site is stably integrated in a HeLa cell line. Upon Doxycycline addition the I-
SceI enzyme is expressed and induces a double strand break at the specific I-SceI site. 
A set of primers targeting the adjacent Ampicilin gene is used to detect the 
recruitment of factors after ChIP. (F) Cell cycle analysis of HeLa-111-ptight cells 
treated with Mimosine or RO3306 and analyzed using Propidium Iodide staining to 
verify G1-S and G2 arrest respectively. See also Figure 1. 
Figure S2 (Related to Figure 2): (A) Schematic representation of the fusion proteins 
stably overexpressed in U2OS cells (GFP and GFP-SET) (B) upper panel: U2OS stable 
cell lines expressing either GFP or GFP-SET. Lower panel: Immunofluorescence of 
endogenous SET in U2OS cells (scale bar: 10 μm). (C) Total cell extracts from U2OS 
GFP and GFP-SET cells were analyzed by Western blot against the proteins GFP, SET 
and tubulin. (D) Biochemical fractionation of U2OS-GFP and U2OS-GFP-SET cells. 
All fractions were analyzed by Western blot. (E) Clonogenic survival of U2OS cells 
stably overexpressing GFP or GFP-SET with increasing concentrations of 
Phleomycin. SEM represents the errors from 3 independent experiments. Statistical 
significance was calculated using the t-test (P<0,05 *, P<0,01 **, P<0,001 ***). (F) Cell 
cycle analysis of U2OS-GFP (left panel) and U2OS-GFP-SET (right panel) cell lines 
after treatment with 50 μg/ml Phleomycin for 1 h and release for the indicated time 
points using Propidium Iodide staining. (G) BrdU cell cycle analysis of U2OS-GFP 
and U2OS-GFP-SET cells after treatment with 2 mM Hydroxyurea (HU) for 24 hrs 
and release for the indicated time points. (H) Duplication time of U2OS-GFP and 
U2OS-GFP-SET cells. 105
 
 cells from each cell line were grown for 24h, 48h and 72h 
and the total number of cells was measured at the indicated time points. See also 
Figure 2. 
Figure S3 (Related to Figure 3): (A) Left panel: Immunofluorescence staining of 
U2OS GFP and GFP-SET cells with γH2AX after treatment with 10 mM HU for 24h 
and release for another 8 h (scale bar: 10 μm). Right panel: Quantification of γH2AX 
positive cells after treatment with 10 mM HU and release for the indicated time 
points. Photos of at least 100 cells were analyzed for each condition. SEM represents 
the errors from 3 independent experiments. (B) Cell cycle analysis of GFPlacI-lacO 
U2OS cells transfected with flag, flag-SET using Propidium Iodide staining. (C)&(D) 
Quantification of RAD51 foci positive cells (>3 foci per cell) or BRCA1 foci positive 
cells (>5 foci per cell) after treatment with 50 ng/ml NCS and release for the 
indicated time points. SEM represents the errors from 3 independent experiments. 
Statistical significance was calculated using the t-test (P<0,05 *, P<0,01 **, P<0,001 
***). (E) Cell cycle analysis of U2OS-GFP (left panel) and U2OS-GFP-SET (right panel) 
cell lines after treatment with 50 ng/ml NCS for 15 min and release for the indicated 
time points using Propidium Iodide staining. See also Figure 3. 
 
Figure S4 (Related to Figure 4): (A) Cell cycle analysis of lacO U2OS cells transfected 
with flag, flag-SET or mCherrylacI, mCherrylacISET using Propidium Iodide 
staining. (B) Schematic representation of the DR-GFP system. The upstream (5′) GFP 
gene (cassette I) carries a recognition site for I-SceI, a rare-cutting endonuclease that 
does not cleave several eukaryotic genomes tested. The downstream (3′) GFP 
(cassette II) is inactivated by upstream and downstream truncations, leaving only 
~502 bp of GFP. Expression of the meganuclease I-SceI leads to formation of DSBs 
and GFP reconstitution is a marker of HR efficiency. (C) Overexpression of SET (left 
panel) or silencing of SET and BRCA1 (right panel) in DR-GFP cells as confirmed by 
Western blot analysis. (D) Cell cycle analysis of U2OS-DR-GFP cells transfected with 
flag, flag-SET or siSCR, siSET, siBRCA1 using Propidium Iodide staining. (E) 
Schematic representation of the NHEJ system (GCV6 cells). The GCV6 cell line used 
contains a GFP-based NHEJ reporter substrate in which the I-SceI cleavage sites are 
separated by a Kozak ATG cassette which prevents the expression due to a wrong 
ORF. Upon expression of I-SceI the Kozak ATG sequence is cut off the DSBs are 
repaired by NHEJ and there is expression of GFP. (F) Overexpression of SET in 
GCV6 cells as confirmed by Western blot analysis. (G) Quantification of the co-
localization of 53BP1 foci with the lacO array in at least 100 lacO U2OS cells 
transfected with mCherrylacI or mCherrylacISET in the presence or absence of 
transiently overexpressed I-SceI (16 hour transient transfection). SEM represents the 
errors from 3 independent experiments. (H) Quantification of the co-localization of 
53BP1 foci with the lacO array in at least 100 lacO U2OS cells transfected with 
mCherrylacI or mCherrylacISET during a time course of I-SceI inducible expression 
upon Doxycycline addition. SEM represents the errors from 3 independent 
experiments. Statistical significance was calculated using the t-test (P<0,05 *, P<0,01 
**, P<0,001 ***). See also Figure 4. 
 
Figure S5 (Related to Figure 5): (A) Immunoprecipitation (IP) of cell extracts from 
U2OS GFP and GFP-SET cells treated or not with 10 mM of HU in the presence or 
absence of Benzonase using the GFP-trap column. The inputs and eluates were 
analyzed by Western blot against the proteins KAP1 and GFP. (B) U2OS-GFP and 
U2OS-GFP-SET cells were transfected with mCherry or mCherry-KAP1 and the 
extracts were analyzed by Western Blot. (C) U2OS-GFP and U2OS-GFP-SET cells 
were transfected with mCherry or mCherry-KAP1 and fixed after pre-extraction of 
soluble proteins (scale bar: 10 μm). (D) Levels of mCherry intensity were measured 
by an automated microscope. (E) Western blot analysis of whole cell extracts (left 
panel) or histone extracts (right panel) of U2OS-GFP and U2OS-GFP-SET cells 
against GFP, KAP1, SETDB1, HP1α, β and γ, tubulin and H3K9me3. Ponceau 
staining was used to show equal loading on histone extracts. (F) 
Immunofluorescence staining of U2OS-GFP and U2OS-GFP-SET cells for TBP protein 
after pre-extraction of soluble proteins (scale bar: 10 μm). See also Figure 5. 
 
Figure S6 (Related to Figure 6): (A)&(B) Quantification of the colocalization of HP1α 
and HP1β foci with the LacO array in at least 100 lacO U2OS cells transfected with 
mCherryLacI or mCherryLacISET in the presence or absence of I-SceI. SEM 
represents the errors from 3 independent experiments. Statistical significance was 
calculated using the t-test (P<0,05 *, P<0,01 **, P<0,001 ***) (C) U2OS cells expressing 
either GFP or GFP-SET (scale bar: 10 μm). (D) Quantification of the nuclear area as 
defined by DAPI staining. (E) Quantification of positive cells for EdU incorporation 
amongst U2OS-GFP and U2OS-GFP-SET cells. (F) Quantification of EdU positive 
cells in early, mid or late S phase according to their staining pattern in U2OS-GFP 
and U2OS-GFP-SET cells. (G) Quantification of positive cells for EdU incorporation 
in U2OS cells transfected with siSCR or siSET. (H) Quantification of EdU positive 
cells in early, mid or late S phase according to their staining pattern in U2OS cells 
transfected with siSCR or siSET. (I)&(J) Quantification of the co-localization of 
RAD51, BRCA1, CtIP, HP1α, HP1β or HP1γ foci with the LacO array in at least 100 
lacO U2OS cells transfected with mCherrylacI or mCherrylacIKAP1 in the presence 
or absence of I-SceI. SEM represents the errors from 3 independent experiments. 
Statistical significance was calculated using the t-test (P<0,05 *, P<0,01 **, P<0,001 
***). See also Figure 6. 
Figure S7 (Related to Figure 7): (A) Schematic representation of HP1γ tethering on 
the lacO-lacI/I-SceI system. (B) Immunofluorescence staining of the lacO U2OS cells 
transfected with GFPlacIHP1γ with γH2AX antibody in the presence or absence of I-
SceI showing the colocalization of γH2AX foci with the lacO array in the presence of 
I-SceI (scale bar: 10 μm). (C) Quantification of the colocalization of 53BP1 foci with 
the lacO array in at least 100 lacO U2OS cells transfected with GFPlacI or 
GFPlacIHP1α, GFPlacIHP1β or GFPlacIHP1γ in the presence or absence of I-SceI. (D) 
Quantification of the colocalization of RAD51 foci with the lacO array in at least 100 
lacO U2OS cells transfected with siSCR or siSET, followed by transfection with 
GFPlacI or GFPlacIHP1γ in the presence or absence of I-SceI. Silencing of SET was 
verified by Western blot. (E) Quantification of the colocalization of P-RPA32 S4/8 
foci with the lacO array in at least 100 lacO U2OS cells transfected with siSCR or 
siHP1γ, followed by transfection with mCherrylacI or mCherrylacISET in the 
presence or absence of I-SceI. (F) Quantification of the colocalization of RAD51, 
BRCA1 and P-RPA32 S4/8 foci with the lacO array in at least 100 lacO U2OS cells 
transfected with siSCR or siHP1α or siHP1β, followed by transfection with 
mCherrylacI or mCherrylacISET in the presence or absence of I-SceI. (G) Silencing of 
HP1α, β and γ as confirmed by Western blot analysis. See also Figure 7. 
Supplemental Experimental Procedures 
siRNA screen 
Screening was performed at the high throughput screening facility of the IGBMC, 
using a custom siRNA library (Dharmacon) of chromatin related and phosphatome 
siRNA smartpool (4 different siRNAs/pool). Controls were performed with 
smartpool siRNAs from Dharmacon (Thermo Scientific): siRNAs against human 
XRCC4 (positive control) and siGFP (negative control). For each target, 25 nM final 
concentration of siRNA is reverse transfected in 5,000 HeLa cells per 0.3 cm2 by 
using Interferin (Polyplus). All screens were performed in 96-well cell culture 
microplates with a particular focus on avoiding microplate edge effects. γH2AX and 
53BP1 foci were analyzed by immunofluorescence 3 days after siRNA transfection 
and 16 hrs after NCS treatment (100 ng/mL, 15 min). Cells were washed, fixed with 
3% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with 2% BSA, 
and incubated with γH2AX and 53BP1 antibodies followed by Alexa Fluor 488 and 
568 conjugated second antibodies (Invitrogen). Cell nuclei are counterstained with 1 
µg/mL DAPI. The screens were achieved owing to a TECAN robotic station (for cell 
transfection, staining, and immunocytochemistry) and to a Caliper Twister II robotic 
arm coupling microplate stacks to the InCELL1000 analyzer microscope (GE 
LifeSciences). Images were acquired with the InCELL1000 analyzer microscope (GE 
LifeSciences) and analyzed with the Multi Target Analyzer from GE Healthcare 
(γH2AX intensity and 53BP1 foci counting). Datasets were analyzed via 
RReportGenerator software (Wolfgang Rafelsberger, IGBMC). 
Laser microirradiation 
For 405 nm UV-laser irradiation, experiments were carried out as described by 
Kruhlak et al., (2006). Briefly, cells pre-treated with 2 uM Hoechst 33342 (Sigma-
Aldrich) for 5 min were imaged at 37oC using a custom built Zeiss Cell Observer 
Microscope (Intelligent Imaging Innovations (3i), Boulder, Co), equipped with a 
heated CO2 incubator, diode-based lasers (405, 488, 561, and 633 nm) and a spinning-
disk confocal scanning unit X1 (CSU-X1)(Yokagawa, Japan) using a 40× (1.4 NA) 
immersion oil objective lens. UV-laser damage was induced by a 100 mW 405 nM 
diode laser using a Vector Scan Unit (3i), where the effective light output was 
measured as ~8 mW at the objective when using 100% power. A single line scan of 
the 405 nm laser at 70% power was sufficient to generate DNA DSBs as demonstrated 
by the rapid recruitment of KU80, which was estimated to be equivalent to ~40-60 Gy 
cellular dose by the method above. Images were captured every 10 s for 6 min, and 
analyzed using an Evolve EMCCD camera (Photometrics) and Slidebook 5.5 software 
(3i), respectively. A minimum of 25 cells were irradiated and tracked over time per 
condition. 
Immunofluorescence 
Cells were grown on glass coverslips, fixed in 4% paraformaldehyde in PBS for 10 
min at room temperature and permeabilized with 0.5 % Triton-X100 in PBS for 10 
min at room temperature. Following permeabilization cells were blocked with 1 % 
BSA in PBS-Tween 0.1%(PBST) for 1 hr at room temperature. Blocked cells are then 
stained with the appropriate primary antibody diluted in 1 % BSA in PBST for 1 hr at 
room temperature. Cells were then washed with PBST and stained with a fluorescent 
secondary antibody (Alexa Fluor, Molecular Probes) for 45 min at room temperature. 
Finally, the cells were washed with PBST and the coverslips were mounted using 
Vectashield with DAPI (Vector Laboratories Inc). In case of pre-extraction of soluble 
proteins, the cells are incubated with Pre-extraction buffer (0.5 % triton-100, 50 mM 
Hepes pH 7, 150 mM NaCl, 10 mM EGTA, 2mM MgCl2) for 30 sec on ice prior to 
fixation. Antibodies used are: mouse anti γH2AX and H3K9me3 (Abcam), rabbit anti 
RAD51 PC130 (Calbiochem), rabbit anti-BRCA1 sc642 (Santa Cruz), mouse anti-CtIP 
clone 14-1 (Active Motif), rabbit anti-P-RPA 32 S4/8 and rabbit anti-53BP1 (Bethyl 
Laboratories), mouse anti KAP1, mouse anti-HP1α, mouse anti-HP1β and mouse 
anti-HP1γ (Εuromedex). In the case of EdU incorporation experiments the Click-iT® 
EdU Alexa Fluor® 488 Imaging Kit was used according to the manufacturer’s 
protocol. 
Tissues from head and neck cancer were deparaffinized and rehydrated. Blocking 
was performed with 1% BSA and 1/20 normal goat serum in TBS. Following, heat 
induced antigen retrieval was carried out in citrate buffer pH: 6.00 for 20 min. The 
antibodies used were rabbit anti-H3K9me3 (1/200, Abcam), rabbit SET (1/50, Santa 
Cruz) and mouse HP1γ (1/200). Tissues were incubated with anti-mouse and anti-
rabbit fluorescent secondary antibodies and DAPI. 
Western blot 
U2OS cells were harvested in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease 
inhibitor cocktail (Roche) and incubated for 15 min on ice before centrifugation (15 
min, 14 000 rpm, 4 °C). The quantity of protein was determined by Bradford (Bio-
Rad). The extracts were analyzed by SDS-PAGE. Primary detection antibodies are 
diluted in 1% non-fat dry milk in PBS. Antibodies used are rabbit anti-SET/I2PP2A 
(santa cruz) or rabbit anti-SET/I2PP2A (Globozymes), mouse anti-phospho-Histone 
H2AX (Ser139) clone JBW301 (Merck Millipore), rabbit anti-H2AX  and goat anti-GFP 
(abcam), , rabbit anti-PChk1, rabbit anti-PChk2, rabbit anti-Chk1 (Cell Signaling), 
mouse anti-Chk2 (Upstate), mouse anti-alpha-tubulin T9026 (Sigma) and anti-XRCC4 
(santa cruz). 
Chromatin Immunoprecipitation (ChIP) 
The ChIP was performed as previously (Lemaitre et al., 2014). Briefly, two 150-mm 
dishes with HeLa-111-ptight cells that were 70% confluent were used for each time 
point. The cells were crosslinked for 30 min in 0.75% (v/v) paraformaldehyde and 
then sonicated in 1% (v/v) SDS-containing sonication buffer (50 mM HEPES, pH 8, 
140 mM NaCl, 1 mM EDTA, 1% (v/v) TritonX-100, 1% (v/v) SDS and a protease 
inhibitor cocktail (Roche)). Thirty milligrams of chromatin were diluted in RIPA 
buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 (v/v), 
0.1% sodium deoxycholate (w/v) and 0.1% SDS (v/v)) and were used in each 
immunoprecipitation by adding 4 μg of antibody and 50 μl of protein-A and protein-
G  sepharose beads (Sigma). The beads were washed for 5 min with low-salt buffer 
(20 mM Tris-HCl, pH 8, 150 mM NaCl, 2 mM EDTA, 1% (v/v) Triton X-100 and 0.1% 
(v/v) SDS), then 5 min with high-salt buffer (20 mM Tris-HCl, pH 8, 500 mM NaCl, 2 
mM EDTA, 1% (v/v) Triton X-100 and 0.1% (v/v) SDS) and for 5 min with LiCl 
buffer (10 mM Tris-HCl, pH 8, 250 mM LiCl, 1 mM EDTA, 1% (v/v) NP-40 and 1% 
(w/v) sodium deoxycholate) and two times for 5 min with TE buffer. The elution 
was done twice at 65 °C for 15 min. Cross-links were reversed by incubation at 65 °C 
for 6 h. The DNA was purified after proteinase K and RNaseA treatment by using 
phenol-chloroform extraction and was resuspended in 50 μl of TE buffer. The signal 
in each experiment was calculated using the formula (immunoprecipitated sample–
IgG control)/input, and each value represents a relative DNA concentration that is 
based on the standard curve of the input. 
 
Histone extraction 
Cells were harvested and washed twice with ice cold PBS. The cells were then 
resuspended in Triton extraction buffer (TEB) (0.5 % triton X-100, 2 mM PMSF, 0.02 
% NaN3, 1X PBS) at cell density of 107 cell/mL and were incubated on ice for 10 min 
with gentle stirring before being centrifuged at 2000 rpm for 10 min at 4 °C. The 
pellet was then washed in half the volume of TEB, centrifuged and resuspended in 
0.2 N HCl at a cell density of 4x107
Cell cycle analysis 
 cell/mL and incubated overnight at 4 °C. Finally 
the supernatant was collected, the protein quantity was determined using Bradford 
(Bio-Rad) and the samples were analyzed by western blot. 
U2OS cells were treated either with phleomycin (1 h 50 μg/mL) or hydroxyurea (24h 
10 mM) and released in fresh medium for the indicated time points. For cell cycle 
arrest experiments Mimosine (0,5 mM for 24h) was used for arrest of cells in G1-S 
and RO3306 (10 uM for 24h) for arrest in G2. The cells were collected using trypsin 
and fixed in ice-cold 70 % ethanol. The following day the cells were incubated in 
Propidium Iodide buffer for 30 min just before FACS analysis. For BrdU staing: BrdU 
(10 µM) (Sigma) was added 10 min before cell collection. Fixed cells were incubated 
in pepsine buffer (0.5 mg/mL pepsine, 30 mM HCl) for 10min at 37°C and in HCl 2N 
for 20 min at room temperature. Anti-BrdU antibody (Roche) was added for 45 min 
before the addition of the secondary antibody (Alexa Fluor, Molecular Probes) for 30 
min. Finally cells are washed and incubated in Propidium Iodide buffer and 
analyzed by FACS. Acquisition of the data is performed through Cell Quest software, 
and analysis through FlowJo and ModFit.  
Survival assays 
U2OS cells were plated in 6 well plates in triplicates (500 cells per well) and were 
subsequently treated with increasing concentrations of either phleomycin (Sigma) or 
camptothecin (Sigma) for 1 hour. The cells were then released with the addition of 
fresh medium and were let to grow in colonies for 10 days. After 10 days, the cells 
were washed with PBS, fixed with 4% Formaldehyde for 30 minutes and stained with 
Crystal Violet (0,1% w/v) for 1 hrr. The number of colonies per well was measured 
by ImageJ. 
Comet assay 
Neutral Comet assay was performed according to the manufacturer’s protocol 
(Trevigen Kit for Comet assay). Briefly, U2OS cells were treated with NCS (200 
ng/ml) for 15 minutes and were collected either immediately or 16 hours after the 
treatment. 5000 cells from each condition were combined with Low Melting Agarose 
(LMAgarose) at a ratio of 1:5 and were placed onto a CometSlide. The slides were 
treated according to the Trevigen kit protocol and were finally electrophorized for 15 
min at 21 V at 4o
RNA extraction and RT-qPCR 
C. The slides were subsequently stained with SYBR green and 
photos were acquired using a Leica epifluorescence microscope DM600B. Photos of 
at least 100 cells were analyzed by CometScore and the average Comet Tail Moment 
was measured. 
RNA was extracted from cells using the RNeasy kit (Qiagen) according to the 
manufacturer instructions. RT-qPCR was then performed with the Quantitect SYBR 
Green RT-PCR Kit (Qiagen) in the LightCycler 480 system (Roche). 
 
Human samples 
  
Formalin-fixed, paraffin-embedded specimens from 10 surgically removed colon 
carcinomas and 15 head and neck carcinomas were analyzed, after local ethical 
committee approval. In addition, adjacent normal tissue was included from each 
specimen examined. Patients had not undergone any chemo-, radio- or 
immunotherapy prior to surgical resection, to avoid any influence in the expression 
status of the examined factors. The majority of the samples have been described in 
previous reports (Liontos et al., 2007; Evangelou et al., 2013). 
 
Immunohistochemistry (IHC) 
Method: An immunoperoxidase staining was performed on serial sections of the 
tissues using the UltraVision LP Detection System kit from Thermo Scientific. Heat 
induced antigen retrieval was carried out in citrate buffer pH: 6.00 for 25 min. The 
antibodies used were anti-H3K9me3 (1/1.500+1/40 goat serum, Abcam), SET (1/500, 
Santa Cruz) and HP1γ (1/600, Millipore). For color development we used 3,39-
diaminobenzidine tetrahydrochloride (DAB) and hematoxylin as counterstain. For 
tissue sections observation and image capturing a Leica microscope was employed.  
Evaluation: Only nuclear staining was taken into consideration. The IHC staining was 
evaluated under optical microscope in 5 high-power fields (X400) per slide. The 
selected fields were identical in all serial sections to enable optimal comparison. The 
evaluation was done by 2 independent qualified pathologists. 
Controls: Colon carcinoma sections were used as positive controls as suggested by the 
antibody manufacturer. As negative controls tissue sections stained by omitting 
application of the primary antibody were used. 
